XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/uncategorized/newsomeros-reports-positive-data-from-phase-i-multiple-ascending-dose-trial-of-oms824/20%Daily2013-03-27 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsanthera-commences-phase-iii-study-of-lupus-drug-blisibimod/20%Daily2013-03-27 18:30
https://www.clinicaltrialsarena.com/uncategorized/newslundbeck-otsuka-collaborate-to-develop-lu-ae58054-as-alzheimers-disease-therapy/20%Daily2013-03-26 18:30
https://www.clinicaltrialsarena.com/uncategorized/newscatabasis-commences-phase-i-hypertriglyceridemia-study-of-cat-2003/20%Daily2013-03-26 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsbiocryst-commences-phase-i-hereditary-angioedema-trial-of-bcx4161/20%Daily2013-03-25 18:30
https://www.clinicaltrialsarena.com/uncategorized/newstrius-tedizolid-meets-endpoints-in-phase-iii-absssi-study/20%Daily2013-03-25 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsintarcia-begins-patient-enrolment-in-freedom-1-type-ii-diabetes-trial-of-itca-650/20%Daily2013-03-24 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsohr-reports-data-from-ohravr118-phase-ii-cancer-cachexia-trial/20%Daily2013-03-24 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsaffinium-reports-positive-results-from-phase-iia-study-of-afn-1252/20%Daily2013-03-21 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsteva-reports-positive-data-from-phase-iii-multiple-sclerosis-study-of-laquinimod/20%Daily2013-03-21 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsamgen-reports-positive-top-line-results-from-melanoma-drug-phase-iii-trial/20%Daily2013-03-20 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsalder-biopharmaceuticals-doses-first-patients-in-ald403-phase-ii-study/20%Daily2013-03-20 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsalnylam-commences-ttr-mediated-amyloidosis-drug-phase-i-study/20%Daily2013-03-19 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsegen-commences-ovarian-cancer-drug-phase-i-trial/20%Daily2013-03-19 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsr-tech-ueno-begins-patient-enrolment-in-unoprostone-phase-iii-study/20%Daily2013-03-18 18:30
https://www.clinicaltrialsarena.com/uncategorized/newseli-lilly-ed-drug-cialis-meets-primary-endpoint-in-phase-iii-study/20%Daily2013-03-18 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsamag-reports-positive-preliminary-data-from-ferumoxytol-extension-study/20%Daily2013-03-17 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsdiffusion-pharma-completes-patient-enrolment-in-phase-ii-trial-of-anti-cancer-agent/20%Daily2013-03-17 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsn30-pharma-commences-patient-treatment-in-cystic-fibrosis-drug-phase-ibiia/20%Daily2013-03-14 18:30
https://www.clinicaltrialsarena.com/uncategorized/newssinovac-reports-positive-preliminary-top-line-data-from-ev71-phase-iii-trial/20%Daily2013-03-14 18:30
https://www.clinicaltrialsarena.com/uncategorized/newslithera-commences-fat-reduction-drug-lipo-202-phase-iib-trial/20%Daily2013-03-13 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsbiothera-completes-patient-enrolment-in-phase-iib-lung-cancer-trial/20%Daily2013-03-13 18:30
https://www.clinicaltrialsarena.com/uncategorized/newssosei-commences-phase-iii-oropharyngeal-candidiasis-study-of-so-1105/20%Daily2013-03-12 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsradius-completes-enrolment-in-osteoporosis-drug-phase-iii-study/20%Daily2013-03-12 18:30
https://www.clinicaltrialsarena.com/uncategorized/newspfizer-reminder-trial-of-inspra-meets-primary-composite-efficacy-endpoint/20%Daily2013-03-11 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsziopharm-commences-phase-ii-ad-rts-il-12-palifosfamide-drug-combination-study/20%Daily2013-03-11 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsoncomed-commences-solid-tumor-drug-phase-1-study/20%Daily2013-03-10 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsgilead-reports-positive-data-phase-4-terisa-study-ranexa/20%Daily2013-03-10 18:30
https://www.clinicaltrialsarena.com/uncategorized/newspoxel-initiates-type-2-diabetes-drug-phase-iib-study/20%Daily2013-03-07 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsadma-biologics-doses-first-patient-in-pidd-drug-phase-iii-study/20%Daily2013-03-07 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsucb-presents-positive-results-from-phase-iii-study-of-epilepsy-drug/20%Daily2013-03-06 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsteva-active-biotech-enrol-first-patient-in-rrms-drug-phase-iii-study/20%Daily2013-03-06 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsroche-wins-european-approval-for-metastatic-breast-cancer-drug/20%Daily2013-03-05 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsgalectin-to-commence-phase-i-clinical-study-of-fatty-liver-disease-drug/20%Daily2013-03-05 18:30
https://www.clinicaltrialsarena.com/uncategorized/newspsioxus-completes-patient-enrolment-in-cancer-cachexia-drug-phase-ii-study/20%Daily2013-03-04 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsneuroderm-reports-positive-phase-i-study-results-of-parkinsons-disease-drug/20%Daily2013-03-04 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsadventrx-to-develop-anx-188-drug-for-acute-limb-ischemia/20%Daily2013-03-03 18:30
https://www.clinicaltrialsarena.com/uncategorized/newskythera-reports-positive-interim-results-phase-iiib-for-injectable-double-chin-treatment/20%Daily2013-03-03 18:30